ADIL Adial Pharmaceuticals Inc

2.73
+0.04  (+2%)
Previous Close 2.69
Open 2.68
Price To Book 6.21
Market Cap 27708875
Shares 10,143,826
Volume 13,169
Short Ratio
Av. Daily Volume 423,406

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 European trial planned 1H 2019.
AD04
Alcohol use disorder

Latest News

  1. Adial Pharmaceutical's Chief Medical Officer Dr. Bankole Johnson Featured on NBC West Palm Beach, Florida Affiliate
  2. Adial Pharmaceuticals Announces Appointment of Alex Lugovoy as Head of Strategy
  3. Bankole A. Johnson, M.D., Chief Medical Officer of Adial Pharmaceuticals Delivers Keynote Lecture; Receives Prestigious American Society of Addiction Medicine Award
  4. Adial Pharmaceuticals Announces Open Market Purchases of Common Stock by Chief Medical Officer, Bankole Johnson, M.D.
  5. Adial Pharmaceuticals Announces Appointment of Bankole Johnson, M.D., as Chief Medical Officer
  6. Adial Pharmaceuticals Announces Filing to Update the Prior Registration Statement Registering the Shares Underlying the ADILW Warrants
  7. Adial CEO: A Medical Solution For Alcoholism Could Be Just Around The Corner
  8. Adial Pharmaceuticals Featured on CBS in San Francisco
  9. Adial Pharmaceuticals Announces Closing of $9.2 Million Underwritten Public Offering and Exercise of Underwriters’ Over-Allotment Option
  10. Four Biotech Stocks Setting The Standard On Thursday (2/21/19)
  11. Adial Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering
  12. Adial Pharmaceuticals Announces Partnership with Catalent to Package and Distribute Adial’s AD04 for its Phase 3 Trial
  13. Adial Pharmaceuticals Submits Continuation Patent Application for Use of AD04 in Opioid Dependence and Abuse
  14. Adial Pharmaceuticals Appoints Leading Addiction Specialist to its Scientific Advisory Board to Advance AD04 and Combat Alcohol Use Disorder
  15. Dr. Bankole A. Johnson, Chairman of Adial Pharmaceuticals, Receives Prestigious American Society of Addiction Medicine Award
  16. Adial Pharmaceuticals CEO to Appear on CBS and Fox Affiliates to Discuss AD04 as a Potential Treatment for Alcohol and Opioid Use Disorder
  17. Adial Pharmaceuticals Receives $1.2 Million in Proceeds Through the Exercise of Warrants
  18. What Kind Of Investor Owns Most Of Adial Pharmaceuticals, Inc. (NASDAQ:ADIL)?
  19. Adial Pharmaceuticals Appoints Two Additional Global Thought Leaders to its Scientific Advisory Board to Advance AD04 and Combat Alcohol Use Disorder
  20. Bankole Johnson, MD and Chairman of the Board of Adial Pharmaceuticals Featured in Second Installment of The Doctors Channel Video Series